DIN 02526816 — VRAYLAR 4.5 MG
VRAYLAR is a capsule of Cariprazine marketed by ABBVIE CORPORATION. The full Cariprazine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02526816
- Brand name
- VRAYLAR
- Active ingredient
- Cariprazine
- Strength
- 4.5 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Atypical antipsychotic (dopamine D3/D2 partial agonist)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cariprazine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02526794 | VRAYLAR | 1.5 MG | CAPSULE | ABBVIE CORPORATION | MARKETED |
| 02526808 | VRAYLAR | 3 MG | CAPSULE | ABBVIE CORPORATION | MARKETED |
| 02526824 | VRAYLAR | 6 MG | CAPSULE | ABBVIE CORPORATION | MARKETED |